Saskia E. Vrouenraets

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study.

Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study.

Journal: The lancet. HIV

Published: December 12, 2023

Switching to Doravirine in cART-Experienced Patients: An Effective and Highly Tolerated Option With Substantial Cost Savings.

Switching to Doravirine in cART-Experienced Patients: An Effective and Highly Tolerated Option With Substantial Cost Savings.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: July 26, 2023

Screening for intra-anal squamous intra-epithelial lesions in women with a history of human papillomavirus-related vulvar or perianal disease: results of a screening protocol.

Screening for intra-anal squamous intra-epithelial lesions in women with a history of human papillomavirus-related vulvar or perianal disease: results of a screening protocol.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: October 08, 2019

Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study.

Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 26, 2013

Low bone mineral density, regardless of HIV status, in men who have sex with men.

Low bone mineral density, regardless of HIV status, in men who have sex with men.

Journal: The Journal of infectious diseases

Published: November 14, 2012

Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue.

Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue.

Journal: HIV clinical trials

Published: April 19, 2012

A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function.

A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function.

Journal: Clinical nephrology

Published: March 27, 2012

Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.

Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.

Journal: AIDS (London, England)

Published: August 23, 2011

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.

Journal: HIV medicine

Published: August 09, 2011

Efavirenz: a review.

Efavirenz: a review.

Journal: Expert opinion on pharmacotherapy

Published: April 12, 2007

Showing 1-10 of 10

Last Updated: 09/26/2026